FDAnews
www.fdanews.com/articles/113661-repros-announces-that-proellex-reduced-pain-in-phase-2-clinical-trial

Repros Announces That Proellex Reduced Pain in Phase 2 Clinical Trial

January 12, 2009
Repros Therapeutics Inc. released positive results of its recently completed U.S. Phase 2 Proellex endometriosis trial. Proellex is an oral progesterone receptor modulator.
The Earth Times